Brief: Hyloris Announces Approval Of Maxigesic® IV In Eight European Countries

Hyloris Pharmaceuticals SA

07/09/2020 10:10

Sept 7 (Reuters) - Hyloris Pharmaceuticals SA  HYL.BR :
    * HYLORIS ANNOUNCES APPROVAL OF MAXIGESIC® IV IN EIGHT
EUROPEAN
COUNTRIES
    * COMMERCIALIZATION OF HYLORIS' SECOND MARKETED PRODUCT TO
START
IN EARLY 2021
    * ADDITIONAL PROCEDURES HAVE BEEN INITIATED TO OBTAIN
APPROVAL IN
FURTHER COUNTRIES WITHIN EU.
    * NDA FILING OF MAXIGESIC® IV IN US IS EXPECTED TO OCCUR BY
END OF
2020

Source text for Eikon:  ID:nGNE339TxX 
Further company coverage:  HYL.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))